Cellosaurus logo
expasy logo

Cellosaurus SCCRDEB3 (CVCL_G304)

[Text version]
Cell line name SCCRDEB3
Synonyms SCCRDEB 3
Accession CVCL_G304
Resource Identification Initiative To cite this cell line use: SCCRDEB3 (RRID:CVCL_G304)
Sequence variations
  • Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=24662767).
  • Mutation; HGNC; 2214; COL7A1; Simple; p.Arg525Ter (c.1573C>T); ClinVar=VCV000279785; Zygosity=Heterozygous (PubMed=21602893).
  • Mutation; HGNC; 2214; COL7A1; Simple; p.Arg578Ter (c.1732C>T); ClinVar=VCV000372330; Zygosity=Heterozygous (PubMed=21602893).
  • Mutation; HGNC; 6407; KRAS; Simple; p.Lys176Arg (c.527A>G); Zygosity=Unspecified (PubMed=24662767).
  • Mutation; HGNC; 7881; NOTCH1; Simple; p.Arg353Cys (c.1057C>T); Zygosity=Unspecified (PubMed=24662767).
  • Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=21602893; PubMed=24662767).
Disease Epidermolysis bullosa dystrophica (NCIt: C84691)
Skin squamous cell carcinoma (NCIt: C4819)
Dystrophic epidermolysis bullosa (ORDO: Orphanet_303)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 36Y
Category Cancer cell line
Publications

PubMed=21602893; DOI=10.1038/onc.2011.180
Watt S.A., Pourreyron C., Purdie K.J., Hogan C., Killick-Cole C.L., Foster N., Pratt N., Bourdon J.-C., Appleyard V., Murray K., Thompson A.M., Mao X., Mein C.A., Bruckner-Tuderman L.K., Evans A., McGrath J.A., Proby C.M., Foerster J., Leigh I.M., South A.P.
Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma.
Oncogene 30:4666-4677(2011)

PubMed=22006338; DOI=10.1073/pnas.1114669108
Wang N.J., Sanborn Z., Arnett K.L., Bayston L.J., Liao W., Proby C.M., Leigh I.M., Collisson E.A., Gordon P.B., Jakkula L.R., Pennypacker S., Zou Y., Sharma M., North J.P., Vemula S.S., Mauro T.M., Neuhaus I.M., LeBoit P.E., Hur J.S., Park K., Huh N., Kwok P.-Y., Arron S.T., Massion P.P., Bale A.E., Haussler D., Cleaver J.E., Gray J.W., Spellman P.T., South A.P., Aster J.C., Blacklow S.C., Cho R.J.
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.
Proc. Natl. Acad. Sci. U.S.A. 108:17761-17766(2011)

PubMed=24662767; DOI=10.1038/jid.2014.154
South A.P., Purdie K.J., Watt S.A., Haldenby S., den Breems N.Y., Dimon M., Arron S.T., Kluk M.J., Aster J.C., McHugh A., Xue D.J., Dayal J.H.S., Robinson K.S., Rizvi S.M.H., Proby C.M., Harwood C.A., Leigh I.M.
NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis.
J. Invest. Dermatol. 134:2630-2638(2014)

PubMed=29755650; DOI=10.18632/oncotarget.24750
McHugh A., Fernandes K., South A.P., Mellerio J.E., Salas-Alanis J.C., Proby C.M., Leigh I.M., Saville M.K.
Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity.
Oncotarget 9:20265-20281(2018)

Cross-references
Cell line databases/resources cancercelllines; CVCL_G304
Encyclopedic resources Wikidata; Q54952393
Polymorphism and mutation databases Cosmic; 1608866
Cosmic; 2688671
Entry history
Entry creation11-Feb-2013
Last entry update05-Oct-2023
Version number14